Loading…

Prevalence of Pertussis Antibodies in Maternal Delivery, Cord, and Infant Serum

Background. Passively acquired maternal antibodies protect infants from many pathogens. With increasing reports of infant pertussis, we evaluated pertussis antibodies in maternal-infant paired sera from 1999–2000. Methods. Antibodies to pertussis toxin (PT), filamentous hemagglutinin (FHA), and fimb...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of infectious diseases 2004-07, Vol.190 (2), p.335-340
Main Authors: Healy, C. Mary, Munoz, Flor M., Rench, Marcia A., Halasa, Natasha, Edwards, Kathryn M., Baker, Carol J.
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background. Passively acquired maternal antibodies protect infants from many pathogens. With increasing reports of infant pertussis, we evaluated pertussis antibodies in maternal-infant paired sera from 1999–2000. Methods. Antibodies to pertussis toxin (PT), filamentous hemagglutinin (FHA), and fimbrial proteins (FIM) were measured by validated IgG-specific enzyme-linked immunosorbant assay (ELISA) in 64 maternal-umbilical cord serum pairs and in 61 of 64 infant sera. Geometric mean concentrations (GMCs) of pertussis antibodies and cord:maternal GMC ratios were calculated. Results. Mean maternal age and gestation were 29.7 years (range, 19–42) and 39.3 weeks (range, 35.67–40.9), and 81% of mothers were white. GMCs of maternal antibodies at delivery (ELISA units/mL) were 2.4 for PT, 6.9 for FHA, and 13 for FIM. Cord GMCs were 169%, 178%, and 157% of maternal delivery values for PT, FHA, and FIM, respectively, demonstrating active placental transfer (P
ISSN:0022-1899
1537-6613
DOI:10.1086/421033